HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of selected oral chemotherapeutants against Ichthyophthirius multifiliis (Ciliophora: Ophyroglenidae) infecting rainbow trout Oncorhynchus mykiss.

Abstract
The chemotherapeutic efficacy of 6 in-feed compounds against Ichthyophthirius multifiliis Fouquet, 1876 was assessed using experimental infections of rainbow trout Oncorhynchus mykiss (Walbaum) fingerlings. Trial doses of 104 ppm amprolium hydrochloride or 65 ppm clopidol fed to fish for 10 d prior to infection significantly reduced the number of trophonts establishing in trout fingerlings by 62.0 and 35.2% respectively. In-feed treatments of infected trout with either 63 or 75 ppm amprolium hydrochloride, 92 ppm clopidol, or 38, 43 or 47 ppm salinomycin sodium for 10 d also significantly reduced the number of surviving trophonts by 77.6 and 32.2% for amprolium, 20.1% for clopidol and 80.2, 71.9 and 93.3% respectively for salinomycin sodium.
AuthorsAndrew P Shinn, Rodney Wootten, Isabelle Côté, Christina Sommerville
JournalDiseases of aquatic organisms (Dis Aquat Organ) Vol. 55 Issue 1 Pg. 17-22 (Jun 20 2003) ISSN: 0177-5103 [Print] Germany
PMID12887250 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiprotozoal Agents
  • Pyrans
  • Nicarbazin
  • Decoquinate
  • salinomycin
  • Clopidol
  • Monensin
  • Amprolium
Topics
  • Administration, Oral
  • Amprolium (therapeutic use)
  • Animal Feed
  • Animals
  • Antiprotozoal Agents (administration & dosage, therapeutic use)
  • Ciliophora (drug effects, growth & development)
  • Ciliophora Infections (drug therapy, veterinary)
  • Clopidol (administration & dosage, therapeutic use)
  • Decoquinate (administration & dosage, therapeutic use)
  • Dose-Response Relationship, Drug
  • Fish Diseases (drug therapy, parasitology)
  • Monensin (administration & dosage, therapeutic use)
  • Nicarbazin (administration & dosage, therapeutic use)
  • Oncorhynchus mykiss (parasitology)
  • Pyrans (administration & dosage, therapeutic use)
  • Random Allocation
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: